Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma

Clinical trial NCT00053326 · COMPLETED

Trial details

NCT number: NCT00053326
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Neuroblastoma

Start date: 2003-05-01
Primary completion: 2006-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.